ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 38487549

Serum myostatin as a candidate disease severity and progression biomarker of spinal muscular atrophy.

de Albuquerque ALA and 9 others. Brain Commun, 2024. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Serum myostatin as a candidate disease severity and progression biomarker of spinal muscular atrophy. Papers, record 38487549. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38487549

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serum myostatin as a candidate disease severity and progression biomarker of spinal muscular atrophy.
PubMed
Journal
Brain Commun
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
2.52, provisional
iCite
Revised in PubMed
2024-03-16
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Albuquerque ALAAna Letícia Amorim
2Chadanowicz JKJúlia Kersting
3Giudicelli GCGiovanna Câmara
4Staub ALPAna Lucia Portella
5Weber ACArthur Carpeggiani
6Silva JMSJordana Miranda De Souza
7Becker MMMichele Michelin
8Kowalski TWThayne Woycinck
9Siebert MMarina
10Saute JAMJonas Alex Morales

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,123,861NFL is a marker of treatment response in children with SMA treated with nusinersen.J Neurol2019https://conductscience.org/library/papers/31123861PubMed
220,578,137Newborn and carrier screening for spinal muscular atrophy.Am J Med Genet A2010https://conductscience.org/library/papers/20578137PubMed
322,388,286Fast gapped-read alignment with Bowtie 2.Nat Methods2012https://conductscience.org/library/papers/22388286PubMed
431,589,162Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment.J Clin Invest2019https://conductscience.org/library/papers/31589162PubMed
533,991,176Increased systemic HSP70B levels in spinal muscular atrophy infants.Ann Clin Transl Neurol2021https://conductscience.org/library/papers/33991176PubMed
631,707,373Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care.J Neuromuscul Dis2020https://conductscience.org/library/papers/31707373PubMed
734,484,951Molecular Biomarkers for Spinal Muscular Atrophy: A Systematic Review.Neurol Clin Pract2021https://conductscience.org/library/papers/34484951PubMed
834,759,311Elevated circulating follistatin associates with an increased risk of type 2 diabetes.Nat Commun2021https://conductscience.org/library/papers/34759311PubMed
922,047,105Spinal muscular atrophy.Orphanet J Rare Dis2011https://conductscience.org/library/papers/22047105PubMed
1032,961,888MiRNAs, Myostatin, and Muscle MRI Imaging as Biomarkers of Clinical Features in Becker Muscular Dystrophy.Diagnostics (Basel)2020https://conductscience.org/library/papers/32961888PubMed

1 to 10 of 50

See all 50 references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42,929,233Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response.Ann Clin Transl Neurol2026https://conductscience.org/library/papers/42929233PubMed
42,439,637Unveiling the Mysteries of CLEC3B: Physiological Roles, Pathological Impacts, and Research Gaps.Cells2026https://conductscience.org/library/papers/42439637PubMed
42,310,398Ten years of disease-modifying therapy in spinal muscular atrophy: lessons learned and future directions.Nat Rev Neurol2026https://conductscience.org/library/papers/42310398PubMed
42,298,331Creatine/Creatinine Ratio and Myostatin as Biomarkers to Monitor Muscle Function in Duchenne Muscular Dystrophy Patients.J Cachexia Sarcopenia Muscle2026https://conductscience.org/library/papers/42298331PubMed
40,757,029Biomarkers in spinal muscular atrophy.Front Neurol2025https://conductscience.org/library/papers/40757029PubMed
40,725,131Application of Biomarkers in Spinal Muscular Atrophy.Int J Mol Sci2025https://conductscience.org/library/papers/40725131PubMed
40,640,932Rehabilitation management for patients with spinal muscular atrophy: a review.Orphanet J Rare Dis2025https://conductscience.org/library/papers/40640932PubMed
40,565,321Myostatin Modulation in Spinal Muscular Atrophy: A Systematic Review of Preclinical and Clinical Evidence.Int J Mol Sci2025https://conductscience.org/library/papers/40565321PubMed
40,368,588Myostatin Levels in SMA Following Disease-Modifying Treatments: A Multi-Center Study.Ann Clin Transl Neurol2025https://conductscience.org/library/papers/40368588PubMed
40,193,572In utero therapy for spinal muscular atrophy: closer to clinical translation.Brain2025https://conductscience.org/library/papers/40193572PubMed

1 to 10 of 11

See all 11 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FST10,468PubTator's text mininghttps://conductscience.org/library/genes/10468NCBI Gene
MSTN2,660PubTator's text mininghttps://conductscience.org/library/genes/2660NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38487549

GET https://conductscience.org/api/papers/v1/38487549/references?page=2

API referenceFor AI assistants